This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend Women's Health Professional Care

Co-Located Events


Subpage Hero


09 Jan 2024


BHR Pharmaceuticals Ltd Stand: WH-I30

Antenatal screening by culture of GBS (Streptococcus agalactiae) has reduced perinatal infections. However, its performance associated with a potential change in carriage makes intrapartum antibiotic prophylaxis sometimes risky. 61% of infected infants were born to culture-negative mothers at 8 months.

Accurately and promptly screen parturient on admission and administer antibiotics appropriately.

Intrapartum screening for vaginal or rectal GBS with BIOSYNEX AMPLIFLASH® GBS allows the appropriate administration of antibiotic prophylaxis to positive parturient.

View all Products

Newsletter Sign Up